Neurocords

Spinal Cord Treatment Technology

Health Tech & Life Sciences

Acquired by Orgenesis on Mar, 2025

Acquired Tel Aviv-Yafo Founded 2018

Total raised

—

Stage

Acquired

Founded

2018

Headcount

Tel Aviv-Yafo

Sector

Health Tech & Life Sciences

About

Neurocords is developing regenerative therapies for spinal cord injuries. Its focus is on a novel cellular therapy platform aimed at restoring function following spinal cord injuries.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical Biotechnology

Business model

B2B

Name	Neurocords
Slug	neurocords
Type	Israeli Startup
Founded	2018
HQ city	Tel Aviv-Yafo
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object]
Business models	B2B
Status	acquired
Current stage	Acquired
Public stage	Acquired
Total raised (USD)	0
Israeli Companies Registrar	515813897

Neurocords

About

Sectors & technology

Neurocords — Full Company Profile (machine-readable)

About

Facts

Acquisitions (1)

News mentions (1)

About

Sectors & technology

Generate Slim Page